Shumilov, Evgenii, Rebecca Wurm-Kuczera, Joseph Kauer, Meng Wang, Paolo Mazzeo, Hristo Boyadzhiev, Niklas Gebauer, Udo Holtick, Alexander Hölscher, Marcel Teichert, Paulina Maria Nierychlewska, Christoph Kimmich, Philipp Berning, Thomas Melchardt, Vanja Zeremski, Chiara Wirths, Philipp Nakov, Christian Schultze-Florey, Giuliano Filippini Velazquez, Vadim Lesan, Isabelle Krämer, Florian Kaiser, Ursula Vehling-Kaiser, Anna Ossami-Saidy, Henriette Huber, Akhil Behringer, Martin Bentz, Julia Katharina Scholz, Philipp Gödel, Ulf Schnetzke, Vladan Vucinic, Elisabeth Shorb, Susanne Ghandili, Andrea Kerkhoff, Sebastian Scheich, Semra Aydin, Karin Mayer, Ulrike Bacher, Kai Wille, Bertram Glass, Thomas Oellerich, Francis Ayuk, Florian Heidel, Lorenz Thurner, Mathias Lutz, Mathias Hänel, Christian W. Scholz, Mareike Tometten, Christiane Pott, Peter Dreger, Dimitrios Mougiakakos, Sascha Dietrich, Enrico Derenzini, Björn Chapuy, Bastian von Tresckow, Thomas Pabst, Fabian Müller, and Georg Lenz. 2020. “Outcomes of Real-World Complete Responders After Fixed-Duration Glofitamab in relapsed/Refractory Large B-Cell Lymphoma”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2025.300063.